KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,419,144 | +71.8% | 262,234 | +73.9% | 0.01% | +83.3% |
| Q2 2023 | $17,708,498 | +417750.4% | 150,839 | +185.0% | 0.01% | +200.0% |
| Q1 2023 | $4,238 | -6.8% | 52,931 | -7.8% | 0.00% | 0.0% |
| Q4 2022 | $4,548 | -99.9% | 57,412 | -32.7% | 0.00% | 0.0% |
| Q3 2022 | $5,947,000 | +6.1% | 85,325 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,604,000 | -0.7% | 85,356 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $5,644,000 | +3.2% | 84,259 | +7.8% | 0.00% | 0.0% |
| Q4 2021 | $5,468,000 | +27.3% | 78,178 | -5.0% | 0.00% | +100.0% |
| Q3 2021 | $4,297,000 | -7.4% | 82,300 | +20.7% | 0.00% | 0.0% |
| Q2 2021 | $4,638,000 | +15.1% | 68,210 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $4,029,000 | +39.4% | 52,296 | +8.5% | 0.00% | 0.0% |
| Q4 2020 | $2,891,000 | +43.0% | 48,191 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $2,022,000 | +10.4% | 46,974 | +6.3% | 0.00% | 0.0% |
| Q2 2020 | $1,831,000 | +1.6% | 44,200 | +6.1% | 0.00% | 0.0% |
| Q1 2020 | $1,802,000 | -17.6% | 41,676 | +5.5% | 0.00% | 0.0% |
| Q4 2019 | $2,187,000 | +55.0% | 39,487 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $1,411,000 | -0.4% | 40,632 | +15.5% | 0.00% | 0.0% |
| Q2 2019 | $1,417,000 | – | 35,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |